IRIS
VITA, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 30.274
NA - Nord America 25.744
AS - Asia 16.394
SA - Sud America 6.066
AF - Africa 461
Continente sconosciuto - Info sul continente non disponibili 25
OC - Oceania 24
AN - Antartide 1
Totale 78.989
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.163
RU - Federazione Russa 14.964
SG - Singapore 7.221
BR - Brasile 5.217
CN - Cina 4.644
IE - Irlanda 3.932
SE - Svezia 2.902
IT - Italia 1.720
HK - Hong Kong 1.612
DE - Germania 1.544
UA - Ucraina 1.239
FR - Francia 1.064
VN - Vietnam 941
FI - Finlandia 885
PL - Polonia 829
GB - Regno Unito 577
IN - India 526
AR - Argentina 287
CA - Canada 239
BD - Bangladesh 237
MX - Messico 184
TR - Turchia 169
EC - Ecuador 159
IQ - Iraq 148
ZA - Sudafrica 123
BE - Belgio 116
ID - Indonesia 107
CO - Colombia 106
PK - Pakistan 103
NL - Olanda 99
AT - Austria 98
MA - Marocco 93
VE - Venezuela 92
UZ - Uzbekistan 90
JP - Giappone 76
ES - Italia 71
CI - Costa d'Avorio 58
CL - Cile 56
PY - Paraguay 54
AZ - Azerbaigian 46
KE - Kenya 44
CZ - Repubblica Ceca 42
PE - Perù 41
TN - Tunisia 40
SA - Arabia Saudita 38
LT - Lituania 37
IR - Iran 35
NP - Nepal 34
JO - Giordania 33
PH - Filippine 33
KZ - Kazakistan 31
AE - Emirati Arabi Uniti 30
IL - Israele 30
MY - Malesia 28
UY - Uruguay 28
EG - Egitto 27
DO - Repubblica Dominicana 26
JM - Giamaica 24
CR - Costa Rica 23
KG - Kirghizistan 23
BO - Bolivia 22
DZ - Algeria 22
OM - Oman 22
AL - Albania 21
EU - Europa 20
RS - Serbia 19
TH - Thailandia 19
LB - Libano 18
HN - Honduras 17
NI - Nicaragua 16
PA - Panama 16
RO - Romania 16
AU - Australia 15
PS - Palestinian Territory 14
CH - Svizzera 13
KR - Corea 11
GT - Guatemala 10
KW - Kuwait 10
SK - Slovacchia (Repubblica Slovacca) 10
SN - Senegal 10
GE - Georgia 9
PT - Portogallo 9
AO - Angola 7
DK - Danimarca 7
ET - Etiopia 7
GA - Gabon 7
HU - Ungheria 7
LK - Sri Lanka 7
MD - Moldavia 7
NZ - Nuova Zelanda 7
QA - Qatar 7
SY - Repubblica araba siriana 7
BA - Bosnia-Erzegovina 6
BY - Bielorussia 6
GR - Grecia 6
MN - Mongolia 6
NO - Norvegia 6
TT - Trinidad e Tobago 6
LA - Repubblica Popolare Democratica del Laos 5
PR - Porto Rico 5
Totale 78.893
Salva come PNG Salva come JPEG
Città #
Moscow 4.726
Dublin 3.926
Singapore 3.427
Ashburn 3.315
Dallas 3.054
Chandler 2.700
Jacksonville 2.564
Nyköping 1.764
Beijing 1.679
Hong Kong 1.595
San Jose 1.043
The Dalles 895
Warsaw 804
Princeton 740
Medford 642
Lauterbourg 632
Cambridge 621
Los Angeles 580
Des Moines 511
Dearborn 487
Ann Arbor 480
Munich 401
Messina 383
São Paulo 378
New York 333
Ho Chi Minh City 331
Buffalo 330
Boardman 299
Council Bluffs 270
Tianjin 211
Wilmington 202
Hanoi 184
San Mateo 173
Shenyang 172
Jinan 167
Rio de Janeiro 166
Guangzhou 155
Woodbridge 148
Orem 146
Turku 145
Redondo Beach 134
Hyderabad 131
Belo Horizonte 128
Bremen 126
Frankfurt am Main 126
Helsinki 124
Nanjing 122
Lancaster 115
Houston 104
Pune 103
Brussels 101
Santa Clara 99
Rome 95
Hebei 94
Brasília 91
Curitiba 90
Ningbo 86
Seattle 85
Shanghai 83
Zhengzhou 82
Chennai 81
Tashkent 79
Hangzhou 72
Porto Alegre 72
Brooklyn 71
Taizhou 70
Tokyo 70
Milan 67
Haikou 65
Baghdad 64
Chicago 63
London 63
Montreal 62
Campinas 60
Vienna 60
Guayaquil 59
Abidjan 58
San Francisco 55
Johannesburg 54
Denver 53
Toronto 53
Nuremberg 52
Atlanta 51
Guarulhos 51
Quito 50
Dong Ket 49
Shenzhen 48
Ribeirão Preto 47
Salvador 47
Baku 46
Stockholm 46
Norwalk 45
Poplar 44
Mexico City 43
Amsterdam 42
Mumbai 42
Boston 40
Dhaka 40
Istanbul 39
Nairobi 39
Totale 45.110
Salva come PNG Salva come JPEG
Nome #
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 366
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 329
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 285
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 258
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 251
A CMT1A PATIENT WITH PAINFUL AND DISABLING SYMPTOMS: FAST RECOVERY AFTER IVIG TREATMENT. 250
Clinical and pathological features of focal myositis 248
HATTR italian registry: preliminary data from the collaborative network of telethon GUP 15010 study 248
Responsiveness of clinical outcome measures in Charcot-Marie-Tooth disease 246
Agenesis of the Internal Carotid Artery Associated with Generalized Epilepsy 239
A Nouvel serum MicroRNA signature to screen ATTR 229
Adolescenti e infezioni sessualmente trasmesse: conoscenze e comportamenti. 228
A 5-center experience with intrathecal administration of nusinersen in SMA1 in Italy letter to the editor of european journal of pediatric neurology regarding the manuscript “single-center experience with intrathecal administration of nusinersen in children with spinal muscular atrophy type 1” written by pechmann and colleagues” 224
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol 220
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC nei gliomi cerebrali diffusi di basso grado: possibili implicazioni cliniche e prognostiche. 218
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 216
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 212
A family with autosomal dominant mutilating neuropathy not linked to either Charcot-Marie-Tooth disease type 2B (CMT2B) or hereditary sensory neuropathy type I (HSN I) loci 211
A cytochemical study of apoptosis in metabolic myopathies 210
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy. 210
BILATERAL PARAMEDIAN THALAMIC INFARCT AFTER OCCLUSION OF THE ARTERY OF PERCHERON. 208
A CLSM study of dystrophin associated proteins and some extra-cellular matrix components in human skeletal muscle 203
A life threatening case of β-enolase deficiency 203
Awareness and behavioural and psychological symptoms of dementia (BPSD) impact in Alzheimer's disease 203
A comparative analysis of somatic and autonomic neuropathy in chronic alcoholics. 199
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 199
A COMPUTER-ASSISTED AUTOMATIC METHOD FOR MYELINATED NERVE-FIBER MORPHOMETRY 198
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 198
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 198
alpha7/beta1 integrin distribution in correlation with talin-vinculin system 195
A decreased muscle content of HPRG correlates with the reduction of AMP deaminase activity observed in patients affected by myoadenylate deficiencies 194
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 194
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 193
Alexithymia, burden and resilience in ALS’ caregivers 193
Behaviour of vinculin and talin in perineurial cells in healthy subjects and in subjects affected by diabteic neuropathy 190
Vacuolated PAS-positive lymphocytes on blood smear: An easy screening tool and a possible biomarker for monitoring therapeutic responses in Late Onset Pompe Disease (LOPD) 190
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 189
Effect of exercise on telomere length and telomere proteins expression in mdx mice 188
Alterazioni neuropsicologiche in emodializzati: confronto tra adulti e anziani 187
Autonomic nervous system involvement in spinal muscular atrophy. 187
Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience 187
Hippo signaling pathway is altered in Duchenne muscular dystrophy 187
Nusinersen versus sham control in later-onset spinal muscular atrophy 186
Characterization and functional analysis of the human microRNA 363 in glioblastoma transfected cell lines 184
[Neuromuscular block induced by fazadinium. Electrophysiological study on fast and slow muscles in the rabbit]. 184
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC: possibili implicazioni cliniche e prognostiche nei gliomi cerebrali diffusi di basso grado 183
Clinical and genotypic of narcoleptic from North eastern Sicily: our sleep centre experience 182
An observational study of functional abilities in infants, children, and adults with type 1 SMA 182
NLRP3 inflammasome CSF expression and neuropsychological changes in idiopathic normal pressure hydrocephalus 182
Bezafibrate-induced myopathy: no evidence for defects in muscle metabolism. 181
A benign case of congenital myotonic dystrophy 181
A checklist for clinical trials in rare disease: Obstacles and anticipatory actions-lessons learned from the FOR-DMD trial 181
Expression of the tumor necrosis factor receptor-associated factors I and 2 and regulation of the nuclear factor-kappa B antiapoptotic activity in human gliomas 179
Central and peripheral autonomic failure in cold induced sweating syndrome type 1 177
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy 177
Fahr's syndrome: local inflammatory factors in the pathogenesis of calcification 176
Sleep and sleep‐modifying factors in chronic migraine patients during the COVID‐19 lockdown 175
ANT1 expression and RAGE-NF-kB pathway activation in sporadic inclusion-body myositis 175
Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls 175
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian center 175
Bilateral paramedian thalamic infarct after occlusion of the artery of Percheron 174
Onset of hypothyroidism with polymyositis-like clinical features in elderly patients 173
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 172
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study. 171
A quantitative analysis of fibers in the controlateral sciatic nerves of the rabbit 170
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 170
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 169
Adult-onset centronuclear myopathy: evidence against a neurogenic pathology. 169
Cardiovascular autonomic control in Becker muscular dystrophy 169
Analisi comparativa della patologia vegetativa autonomica in emodializzati giovani e anziani 169
A novel Cx32 mutation with unusual phenotype. 169
Pilot study of flavocoxid in ambulant DMD patients. 169
Cardiac 99mTc-DPD uptake in subjects with Glu89Gln transthyretin gene mutation: is it the earliest sign of disease development? 168
Pilot study of serial casting of ankles in muscular dystrophy patients. 167
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 167
Espressione differenziale di un panel di miRNA in tumori cerebrali astrogliali con diverso grado di malignità. 167
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 166
Activation of nuclear factor-kappa B in inflammatory myopathies and Duchenne muscular dystrophy 166
Neuropsychological patter in centronuclear myopathy due to DNM2 gene mutations. 166
Is overwork weakness relevant in Charcot-Marie-Tooth disease? 166
Apoptosis and apoptosis-related proteins in thyroid myopathies 165
Pilot study of serial casting in muscular dystrophy patients. 165
Autoimmune juvenile limb-girdle myasthenia 165
Alterazioni neuro psicologiche in emodializzati: confronto tra adulti e anziani 164
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 164
Emergenze respiratorie nelle malattie neurologiche 164
AUDITORY SYSTEM INVOLVEMENT IN LATE ONSET POMPE DISEASE: A STUDY OF 20 ITALIAN PATIENTS 164
A histochemical study of fibre types in rat extraocular muscles 163
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study 163
Myopathy as the persistently isolated symptomatology of primary autoimmune hypothyroidism 162
Increase in synchronization of autonomic rhythms between individuals when listening to music 161
Acute ischemic stroke due to endocarditis from Brucella infection 161
Parenteral nutrition improves nutritional status, autonomic symptoms and qol in patients with TTR-FAP 161
Circadian neurovascular swing: a chronobiological dissynchrony from sleep disorders to cerebrovascular disease 160
Predictors of adaptation to non-invasive ventilation in amyotrophic lateral sclerosis 160
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study 159
Clinical and electrophysiological characterization in a cohort of italian patients with different forms of hereditary spastic paraplegia 159
Deficit multiplo di Acyl-CoA deidrogenasi responsivo alla riboflavina (MADD-RR): studio clinico, biochimico, genetico e spettroscopico 158
Are novel outcome measures for Charcot–Marie–Tooth disease sensitive to change? The 6-minute walk test and StepWatch™ Activity Monitor in a 12-month longitudinal study 158
Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis 158
Totale 19.027
Salva come PNG Salva come JPEG
Categoria #
all - tutte 273.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 273.040
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021161 0 0 0 0 0 0 0 0 0 0 0 161
2021/20224.230 66 582 55 201 275 35 324 199 94 323 521 1.555
2022/202310.860 931 917 491 761 888 1.013 123 607 4.721 40 281 87
2023/20242.590 215 393 195 198 223 545 72 161 29 196 49 314
2024/202513.121 200 135 212 743 549 361 300 2.888 3.298 713 1.383 2.339
2025/202636.571 1.612 2.763 3.084 2.833 2.820 7.992 4.485 4.203 4.249 1.443 650 437
Totale 79.960